Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Statistics

Total Valuation

ENLV has a market cap or net worth of $20.07 million. The enterprise value is $2.56 million.

Market Cap	20.07M
Enterprise Value	2.56M

Important Dates

The last earnings date was Friday, November 28, 2025, after market close.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ENLV has 24.29 million shares outstanding. The number of shares has increased by 20.50% in one year.

Current Share Class	24.29M
Shares Outstanding	24.29M
Shares Change (YoY)	+20.50%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	4.52%
Owned by Institutions (%)	5.25%
Float	23.19M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.15
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.43, with a Debt / Equity ratio of 0.04.

Current Ratio	6.43
Quick Ratio	6.26
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -57.64% and return on invested capital (ROIC) is -40.13%.

Return on Equity (ROE)	-57.64%
Return on Assets (ROA)	-36.02%
Return on Invested Capital (ROIC)	-40.13%
Return on Capital Employed (ROCE)	-81.64%
Revenue Per Employee	n/a
Profits Per Employee	-$178,887
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.39% in the last 52 weeks. The beta is 1.49, so ENLV's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	-33.39%
50-Day Moving Average	1.00
200-Day Moving Average	1.07
Relative Strength Index (RSI)	36.87
Average Volume (20 Days)	1,282,966

Short Selling Information

Short Interest	1.15M
Short Previous Month	170,414
Short % of Shares Out	0.49%
Short % of Float	n/a
Short Ratio (days to cover)	0.12

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.62M
Pretax Income	-12.70M
Net Income	-12.70M
EBITDA	-14.33M
EBIT	-14.62M
Earnings Per Share (EPS)	-$0.54

Balance Sheet

The company has $18.20 million in cash and $701,000 in debt, giving a net cash position of $17.50 million or $0.72 per share.

Cash & Cash Equivalents	18.20M
Total Debt	701,000
Net Cash	17.50M
Net Cash Per Share	$0.72
Equity (Book Value)	17.48M
Book Value Per Share	0.72
Working Capital	16.47M

Cash Flow

In the last 12 months, operating cash flow was -$11.87 million and capital expenditures -$95,000, giving a free cash flow of -$11.97 million.

Operating Cash Flow	-11.87M
Capital Expenditures	-95,000
Free Cash Flow	-11.97M
FCF Per Share	-$0.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.50%
Shareholder Yield	-20.50%
Earnings Yield	-63.30%
FCF Yield	-59.65%

Analyst Forecast

The average price target for ENLV is $7.00, which is 747.46% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	747.46%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1